Follistatin Benefits

Whilst we already know that follistatin integration may lead to massively enhanced muscle growth, we know much less about the other positive benefits it may offer to users.

One study in 2008 displayed positive results in regards to alleviating or even potentially reversing spinal atrophy in mice. This condition, known as “SMA” (Spinal Muscular Atrophy) occurs when spinal motor neurons progressively die, thus leading to the regression (atrophy) of the attached spinal muscles.

This can lead to severely impaired mobility and in worst-case scenarios, the user being completely dependant on a wheelchair for movement.

In mice, lifespan increases of up to 30% were observed when they were treated with follistatin in conjunction with vastly improved musculature, mobility and structural integrity.

As a result, the treatment of this disease is now a major focal point amongst the current tests being performed on humans in the hope that follistatin treatment may be able to send it into regression.

Human Testing – What We Know So Far

Whilst we have previously discussed the human tests currently taking place, we have not at length divulged the details and what we have thus far discovered.

This testing began back in 2015 thanks to a 45 year old woman named Elizabeth Parrish; after years of stagnant debate in regards to whether or not we were truly ready to start human treatment with follistatin, Parrish boldly put a stop to the discussions by nominating herself to be the first person to perform structured scientific research on the substance by serving as a human host.

She did this as part of the company “BioViva” – set up purely as a means of publicising these trials in a bid to encourage others to commence testing with follistatin and other so-called “anti-aging” products.

Animal testing up until that point had in fact yielded very little in regards to concrete negative effects save for some definitive cardiovascular impairment in certain cases.

It should be noted that whilst a fairly high-risk element, cardiovascular impairment is certainly not irregular when implementing any anabolic product whatsoever, especially if the host happens to have underlying genetic deficiencies.

This reason alone shouldn’t have been enough to warrant stalling on human tests for such a prolonged time frame in the grand scheme of things.

As such, it’s to Elizabeth’s credit that she forged ahead and provided us with our first, highly interesting series of results in regards to follistatin use so far.

Whilst the research is still in its infancy, what we have concluded so far (at least in Elizabeth’s case) is that:

● Fat tissue reduction of both a subcutaneous and intracellular nature is likely to occur
● Insulin sensitivity may improve
● White blood cell density and functionality may improve (thus boosting the immune system)
● Muscular maintenance is almost guaranteed
● Blood triglyceride levels are likely to drop
● Nutrient uptake may improve

Further details on the test can be observed here, in conjunction with exact statistics.

Should all of these elements turn out to be accurate, follistatin will indeed be a multi faceted compound capable of delivering tremendous results across a plethora of areas.

We should not overlook the fact that Telomerase Reverse Transcriptase has also been present throughout Elizabeth’s research as she ingested it at the same time as follistatin.

This may have (at least) positively impacted her white blood cell functionality independently to follistatin amongst other potential benefits.

Follistatin And Crazy Muscle Gains – What Human Testing Has Revealed So Far

Being that many people will be reading this profile with a view to ascertaining the muscle gaining benefits on offer when using follistatin, we will now reveal what this early human research has implied, and what kind of results other “unverified” users are currently experiencing.

Over the course of the ongoing test performed by Elizabeth, her body composition has completely altered. Whilst muscle gain has not occurred at a significant level (in terms of what one may expect when taking a strong anabolic steroid type for instance) it has still taken place nonetheless.

In conjunction with this, her body fat has reduced significantly. Combined, these elements have worked together to provide her with a respectably well-pronounced muscular appearance on the whole.

It should be noted that whilst these changes have occurred – her weight has remained the same throughout the integration process.

This apparent lack of “excess” muscle shouldn’t come as much of a surprise; females (as a result of their lowered androgenic capacity) are not biologically able to synthesise lean tissue to the same degree as a male.

You should consider that when using follistatin, we are not directly intervening with muscle cells and “forcing” them into developing beyond their normal means; we are simply working with the anabolic “resources” the body already has at its natural disposal in order to enhance size.

Being that female “resources” in terms of anabolism (and muscular hypertrophy) are naturally limited when compared to those of a males, it stands to reason that any physiological changes relating to muscle mass increase would also be diminished as a result in comparison.

As such, we should consider the results encountered by male users during “unofficial” utilisation phases if we are to try and get a better idea of what the complete “picture” may look like.

This is where things start to get slightly complicated; there are very few user reports containing information that hasn’t been in some way “tainted.”

Amongst the existing reports, there are many users claiming to gain as much as 7 pounds per week, with others claiming no difference whatsoever. As such, it’s difficult to accurately discern what one could reasonably expect to experience when utilising follistatin.

In regards to these individuals, let’s now consider some important variables:

● Follistatin must be used in the manner previously mentioned in regards to ingesting the recombinant version in conjunction with an antibody – the majority of the individuals using follistatin did not follow this procedure
● Many of the users were also using anabolic steroids, including trenbolone
● We do not necessarily know what the users eating and training habits were like
● We do not know anything about the user’s genetic situation

All of these variables and in fact many more would make an enormous difference in regards to the outcome of follistatin integration.

Of particular note is that trenbolone featured in many of these cycle phases; if any steroid variety was capable of mimicking our “ideals” of what follistatin may be capable of, trenbolone would come very close with it offering impressive lean mass gain potential without added adipose tissue when used effectively.

Equally, those who used “wet” gainers during their cycle (steroids that lead to mass gain at the cost of excess fluid retention and fat) may also believe that follistatin is producing an effect that it simply isn’t; the results would potentially be due to the mass gaining steroid instead.

The training and eating habit element isn’t as much of a problem being that follistatin should theoretically be able to lead to unimpeded muscle gain without the necessary nutritional and training stimulus elements needed to create changes, but all humans so far discovered with myostatin deficiency have been in their infancy at the time of diagnosis.

Being that growth acceleration and capacity naturally reduces with age, it’s only fair to state that reasonable nutritional and physical stimulus would likely need to be applied in order to optimise the results of this product in an adult.

We realistically need to observe an adult male performing a rigorous training and nutrition regimen over a sustained period of time whilst integrating recombinant follistatin (plus antibody) within strict scientific confines in order to fully ascertain what it is capable of delivering in terms of excess muscle gain.

Having a female host undergo the exact same regimen would also be necessary, as Elizabeth Parrish isn’t operating in line with the regimen performed by female bodybuilders / aesthetically minded members of society.

Until that time occurs, all we can do is sit and wait whilst hoping that at least some of the implied benefits previously mentioned are soon proved to be definitive.